CMC-544
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CMC-544, covering 2018-10-26 to 2024-07-23. Get the full timeline:
Most recent: Clinical Trial Update: CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies [Phase 1, Phase 2]